Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FBPZD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,008
Award facts
- Contract value 100% obligated
- $33,008.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,008 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The award, issued on December 10, 2025, with an ultimate completion date of January 2, 2026, represents a straightforward procurement of specialty pharmaceutical products to support Department of Defense medical supply requirements. This delivery order was issued without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform all work at its Park Ridge facility with no identified subcontractors involved in the award.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) awarded through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical sourcing for military healthcare facilities worldwide. The parent IDC, awarded on November 13, 2025, carries a $500 million ceiling value and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. The Botox delivery order reflects the ongoing pharmaceutical supply operations under this broad-based vehicle, enabling the DLA to issue firm fixed-price orders for branded pharmaceuticals, generics, biologics, and medical consumables required by Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FBPZD?
SPE2DR26FBPZD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FBPZD worth?
The government has obligated $33,008 on SPE2DR26FBPZD.
Is contract SPE2DR26FBPZD an order under another contract?
Yes. SPE2DR26FBPZD is a delivery order under SPE2DR25D9304, an indefinite delivery contract.
Was contract SPE2DR26FBPZD competed?
The extent of competition for SPE2DR26FBPZD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award